Results 131 to 140 of about 45,340 (263)

Metal/Si Nanowire Arrays for Hot Electron Catalysis

open access: yesSmall, EarlyView.
Silicon nanowire arrays enhance plasmon‐driven catalysis by strengthening light–matter interactions on Au and Ag nanostructured coatings. Hotspot accessibility, rather than near‐field intensity alone, governs photocatalytic performance, while Ag nanoshells exhibit superior activity. The work establishes high‐surface‐area Si nanowire arrays as versatile
Theresa Bartschmid   +7 more
wiley   +1 more source

Osmophobia in Patients With Migraine: A Systematic Review and Meta‐Analysis

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objective To determine the prevalence of osmophobia and to better characterize experiences reported by patients with migraine. Data Sources CINAHL, Cochrane Library, PubMed, and SCOPUS. Methods The literature was searched for articles reporting prevalence of osmophobia in patients with migraine. Primary outcome measures included proportions (%)
Erin E. Briggs   +6 more
wiley   +1 more source

Continuous field assessments and data sharing to rationalize the IUCN's impact in mammal conservation: a case study of Rwanda

open access: yesWildlife Biology, EarlyView.
Taxonomic work, conservation practice, and Red List assessments from the International Union for Conservation of Nature (IUCN) are intricately linked. The primary conservation goal for biodiversity is to halt the factors driving local extinctions of species.
Methode Majyambere   +4 more
wiley   +1 more source

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo   +12 more
wiley   +1 more source

Assessment of Major Adverse Cardiovascular Event Across Diverse Racial Groups of Psoriasis Patients on Biologic Therapy: A Retrospective Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Psoriasis is associated with an increased risk of major adverse cardiovascular events (MACE), and biologic therapy may reduce this risk by targeting systemic inflammation. However, limited data exist on whether long term MACE risk differs by biologic class or across racial groups. We conducted a retrospective cohort study to assess the risk of
Chunghwan Ro   +3 more
wiley   +1 more source

Prognostic role of myosteatosis in predicting MACE and mortality after TAVR: insights from CT-based body composition analysis. [PDF]

open access: yesJ Nutr Health Aging
Li Z   +11 more
europepmc   +1 more source

MACE

open access: yesJournal of JCS Cardiologists, 2004
openaire   +2 more sources

Home - About - Disclaimer - Privacy